2-(7-((5-chlorobenzofuran-2-yl)methyl)-8-oxo-7,8-dihydropyrazino[2,3-d]pyridazin-5-yl)acetic acid | 1355612-91-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: 2-(7-((5-chlorobenzofuran-2-yl)methyl)-8-oxo-7,8-dihydropyrazino[2,3-d]pyridazin-5-yl)acetic acid
• 英文别名: 2-[6-[(5-Chloro-1-benzofuran-2-yl)methyl]-5-oxopyrazino[2,3-d]pyridazin-8-yl]acetic acid
• CAS: 1355612-91-7
• 化学式: C₁₇H₁₁ClN₄O₄
• 分子量: 370.752
• InChiKey: JNQGJVHILXJHHE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  109
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• [EN] ALDOSE REDUCTASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE L'ALDOSE RÉDUCTASE ET LEURS UTILISATIONS
  申请人：UNIV COLUMBIA

  公开号：WO2012009553A1

  公开（公告）日：2012-01-19

  The present invention relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, and the treatment of various other disorders, such as complications arising from diabetes with the compounds and compositions of the invention. Other disorders can include, but are not limited to, atherosclerosis, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, infections of the skin, peripheral vascular disease, stroke, and the like.

  本发明涉及新型化合物及其制药组合物，以及促进皮肤健康老化、治疗皮肤疾病、治疗心血管疾病、治疗肾脏疾病、治疗血管生成异常如癌症、治疗组织损伤如非心脏组织损伤、治疗急性心肌梗死的演变和使用本发明中的化合物和组合物治疗各种其他疾病，如糖尿病并发症等。其他疾病可以包括但不限于动脉粥样硬化、冠状动脉疾病、糖尿病肾病、糖尿病神经病变、糖尿病视网膜病变、皮肤感染、周围血管疾病、中风等。
• ALDOSE REDUCTASE INHIBITORS AND USES THEREOF
  申请人：WASMUTH Andrew

  公开号：US20130225592A1

  公开（公告）日：2013-08-29

  The present invention relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, and the treatment of various other disorders, such as complications arising from diabetes with the compounds and compositions of the invention. Other disorders can include, but are not limited to, atherosclerosis, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, infections of the skin, peripheral vascular disease, stroke, and the like.

  本发明涉及新型化合物及其制药组合物，以及促进皮肤健康老化、治疗皮肤疾病、治疗心血管疾病、治疗肾脏疾病、治疗血管生成障碍（如癌症）、治疗组织损伤（如非心脏组织损伤）、治疗心肌梗死发展以及使用本发明的化合物和组合物治疗其他各种疾病（如糖尿病并发症）。其他疾病可以包括但不限于动脉粥样硬化、冠状动脉疾病、糖尿病肾病、糖尿病神经病、糖尿病视网膜病变、皮肤感染、外周血管疾病、中风等。
• Aldose reductase inhibitors and uses thereof
  申请人：THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

  公开号：US10052324B2

  公开（公告）日：2018-08-21

  The present invention relates to novel compounds and pharmaceutical compositions thereof, and methods for promoting healthy aging of skin, the treatment of skin disorders, the treatment of cardiovascular disorders, the treatment of renal disorders, the treatment of angiogenesis disorders, such as cancer, treatment of tissue damage, such as non-cardiac tissue damage, the treatment of evolving myocardial infarction, and the treatment of various other disorders, such as complications arising from diabetes with the compounds and compositions of the invention. Other disorders can include, but are not limited to, atherosclerosis, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, infections of the skin, peripheral vascular disease, stroke, and the like.

  本发明涉及新型化合物及其药物组合物，以及用本发明化合物和组合物促进皮肤健康老化、治疗皮肤疾病、治疗心血管疾病、治疗肾脏疾病、治疗血管生成疾病（如癌症）、治疗组织损伤（如非心脏组织损伤）、治疗不断发展的心肌梗塞以及治疗各种其他疾病（如糖尿病引起的并发症）的方法。其他疾病包括但不限于动脉粥样硬化、冠状动脉疾病、糖尿病肾病、糖尿病神经病变、糖尿病视网膜病变、皮肤感染、外周血管疾病、中风等。
• US8916563B2
  申请人：——

  公开号：US8916563B2

  公开（公告）日：2014-12-23
• US9650383B2
  申请人：——

  公开号：US9650383B2

  公开（公告）日：2017-05-16